- Home
- SYRS vs FOXO Comparison
SYRS vs FOXO Comparison
Compare SYRS & FOXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYRS
- FOXO
- Stock Information
- Founded
- SYRS 2011
- FOXO 2019
- Country
- SYRS United States
- FOXO United States
- Employees
- SYRS N/A
- FOXO N/A
- Industry
- SYRS Biotechnology: Pharmaceutical Preparations
- FOXO Retail: Computer Software & Peripheral Equipment
- Sector
- SYRS Health Care
- FOXO Technology
- Exchange
- SYRS Nasdaq
- FOXO Nasdaq
- Market Cap
- SYRS 5.7M
- FOXO 4.9M
- IPO Year
- SYRS 2016
- FOXO N/A
- Fundamental
- Price
- SYRS $0.17
- FOXO $0.21
- Analyst Decision
- SYRS Hold
- FOXO
- Analyst Count
- SYRS 5
- FOXO 0
- Target Price
- SYRS $3.00
- FOXO N/A
- AVG Volume (30 Days)
- SYRS 1.2M
- FOXO 2.3M
- Earning Date
- SYRS 03-26-2025
- FOXO 11-19-2024
- Dividend Yield
- SYRS N/A
- FOXO N/A
- EPS Growth
- SYRS N/A
- FOXO N/A
- EPS
- SYRS N/A
- FOXO N/A
- Revenue
- SYRS $386,000.00
- FOXO $1,341,000.00
- Revenue This Year
- SYRS N/A
- FOXO N/A
- Revenue Next Year
- SYRS N/A
- FOXO N/A
- P/E Ratio
- SYRS N/A
- FOXO N/A
- Revenue Growth
- SYRS N/A
- FOXO 196.03
- 52 Week Low
- SYRS $0.16
- FOXO $0.13
- 52 Week High
- SYRS $7.96
- FOXO $1.30
- Technical
- Relative Strength Index (RSI)
- SYRS 38.78
- FOXO 40.68
- Support Level
- SYRS $0.16
- FOXO $0.20
- Resistance Level
- SYRS $0.20
- FOXO $0.25
- Average True Range (ATR)
- SYRS 0.02
- FOXO 0.02
- MACD
- SYRS 0.01
- FOXO 0.00
- Stochastic Oscillator
- SYRS 35.75
- FOXO 16.67
About SYRS Syros Pharmaceuticals Inc.
Syros Pharmaceuticals Inc is a biopharmaceutical company committed to developing new standards of care for the frontline treatment of patients with hematologic malignancies.
About FOXO FOXO Technologies Inc.
FOXO Technologies Inc is a technology platform company focused on commercializing longevity science through products and services that serve the life insurance industry. FOXO's epigenetic technology applies AI to DNA methylation to identify molecular biomarkers of human health and aging. The company has two reportable business segments, FOXO Labs and FOXO Life.